Treatments of hereditary angioedema

The present invention relates to treatments of hereditary angioedema (HAE). In particular, the present invention provides on-demand treatments of hereditary angioedema (HAE) by orally administering a plasma kallikrein inhibitor to a patient in need thereof on-demand. Regular (or continuous) treatmen...

Full description

Saved in:
Bibliographic Details
Main Authors YEA, Christopher Martyn, SMITH, Michael David, MARSH, Sally Louise, FEENER, Edward Paul, MAETZEL, Andreas
Format Patent
LanguageEnglish
Published 15.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to treatments of hereditary angioedema (HAE). In particular, the present invention provides on-demand treatments of hereditary angioedema (HAE) by orally administering a plasma kallikrein inhibitor to a patient in need thereof on-demand. Regular (or continuous) treatments of HAE are also provided.
Bibliography:Application Number: AU20200293614